Adverse Events Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-26 @ 12:48 AM
NCT ID: NCT02621060
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were collected thoughtout the 90 days of the study
Study: NCT02621060
Study Brief: Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo 1200 mg dose per day, three capsules of 400 mg, times daily 1/ 2 hour before meals during 90 days. Placebo: Placebo: 1200 mg per day for three months None None 0 15 3 15 View
Chlorogenic Acid 1200 mg dose per day, three capsules of 400 mg, times daily 1/ 2 hour before meals during 90 days. Chlorogenic acid: Chologenic acid: 1200 mg per day for three months None None 0 15 2 15 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders ANY View
Headacha SYSTEMATIC_ASSESSMENT Nervous system disorders ANY View
polyuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders ANY View
abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders ANY View
abdominal distention SYSTEMATIC_ASSESSMENT Gastrointestinal disorders ANY View